Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Key Points

• The study aims to evaluate the efficacy and safety of brodalumab for managing moderate-to-severe psoriasis over eight years.
• Long-term observational study design
• Assessment of patient outcomes over eight years
• Evaluation of tolerability and disease control
• Brodalumab demonstrates high levels of disease control in patients
• Well-tolerated among patients with moderate-to-severe psoriasis
• Effective for those with previous biologic treatment or complex disease manifestations